Enable job alerts via email!
A biotechnology company is seeking a Director, Clinical Development Scientist to lead clinical strategy for Myasthenia Gravis. The role involves overseeing clinical studies, collaborating with CROs, and contributing to regulatory documents. Candidates should hold an MD, PhD, or PharmD, with experience in rare diseases preferred. The position offers the potential for remote work.
About Us
Dianthus Therapeutics is a publicly traded, clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who are leading the development of next-generation antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.
To learn more, please visit www.dianthustx.com and follow us on LinkedIn.
About the Role
The Director, Clinical Development Scientist will be the clinical and medical primary lead to support the APAC region for our lead program, Myasthenia Gravis (gMG).
Reporting to the Sr. Director, Clinical Development gMG lead, you will steer the preparation, review and execution of clinical study synopses and protocols, investigator brochures, and clinical study reports; review SAPs and TLF shells, guide the evaluation of emerging clinical trial data, oversee/guide the data interpretation and data mining, and ensure assigned studies are conducted according to GCPs and SOPs.
You will act as the medical monitor in close collaboration with the CRO medical and clinical monitors, ensure timely recruitment in collaboration with clinical operations, oversee/guide in conducting literature searches and reviews, meta-analyses, and publishing data. You must have experience with Rare Diseases or Neurology within the biotechnology or pharmaceutical industries.
This is a unique opportunity to join a growing organization with an expanding pipeline and lead clinical strategy for auto-immune neurology indications. We are building a culture of individuals who hold our core principles at the center of our operations, with the goal to elevate the care of our patients' lives. We are open to you working remotely.